# Therapeutic Approaches to HAART-Induced Lipodystrophy

> **NCT00461552** · PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 23 (actual)

## Conditions studied

- HIV Infections
- Lipodystrophy

## Interventions

- **DRUG:** Leptin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00461552
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2019-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00461552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00461552, "Therapeutic Approaches to HAART-Induced Lipodystrophy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00461552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*